Study to Assess the Effect of Multiple Doses of Tradipitant on CYP3A4 Using Midazolam as a Substrate in Healthy Subjects
Completed
Cross Research S.A.
Phase 1
2015-11-01
This study is designed to evaluate the potential effect of administration of tradipitant on
CYP3A4 using midazolam pharmacokinetics as markers.
The study will also further characterize the pharmacokinetics of tradipitant.
Study to Assess the Effect of Multiple Doses of Tradipitant on CYP3A4 Using Midazolam as a Substrate in Healthy Subjects
Completed
Vanda Pharmaceuticals
Phase 1
2015-11-01
This study is designed to evaluate the potential effect of administration of tradipitant on
CYP3A4 using midazolam pharmacokinetics as markers.
The study will also further characterize the pharmacokinetics of tradipitant.
Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis
Completed
Vanda Pharmaceuticals
Phase 2
2016-01-01
This is a multicenter, randomized, double-blind, placebo-controlled study to be conducted in
the United States in subjects with treatment-resistant pruritus diagnosed with atopic
dermatitis.
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
Unknown status
Vanda Pharmaceuticals
Phase 2
2016-11-01
This is a multicenter, randomized, double-blind, placebo-controlled study to be conducted in
the United States. One hundred fifty (150) subjects diagnosed with gastroparesis, who satisfy
the selection criteria for the study, will be randomized to one of two treatment groups,
active or placebo.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models.
By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
